ABSTRACT New Delhi metallo-␤-lactamase 1 (NDM-1) is a subclass B1 metallo-␤-lactamase that exhibits a broad spectrum of activity against ␤-lactam antibiotics. Here we report the kinetic study of 6 Q119X variants obtained by site-directed mutagenesis of NDM-1. All Q119X variants were able to hydrolyze carbapenems, penicillins and first-, second-, third-, and fourth-generation cephalosporins very efficiently. In particular, Q119E, Q119Y, Q119V, and Q119K mutants showed improvements in k cat/ K m values for penicillins, compared with NDM-1. The catalytic efficiencies of the Q119K variant for benzylpenicillin and carbenicillin were about 65-and 70-fold higher, respectively, than those of NDM-1. The Q119K and Q119Y enzymes had k cat /K m values for ceftazidime about 25-and 89-fold higher, respectively, than that of NDM-1.
(5=-CATCTTGTCNNNATGCGCGTGAG), where N represents any of the four base pairs at the codon position to be randomized. The external primers NDM_for (5=-GGGGGGGT ACCCATATGGGTGAAATCCGCCCGA) and NDM_rev (5=-GGGGGGAGCTCGAGTCAGCGC AGCTTGTCGGC) (KpnI/NdeI and SacI/XhoI restriction sites are shown in bold) were used to amplify the entire bla NDM-1 gene. The amplification product, digested with KpnI and SacI, was ligated into the pBC-SK(ϩ) Bluescript vector, and the ligation product was transformed into Escherichia coli XL-1 Bluescript cells. Functional random mutants were selected by growth in the presence of chloramphenicol (30 g/ml), ampicillin (100 g/ml), and meropenem (1 g/ml) and then were sequenced (ABI Prism 3500 eightcapillary automated sequencer; Life Technologies, Monza, Italy) to identify the amino acid substitutions at the randomized position. Among functional clones, 11 NDM-1 mutants were identified, i.e., Q119I, Q119S, Q119L, Q119Y, Q119C, Q119T, Q119F, Q119K, Q119V, Q119E, and Q119M. The phenotypic profiles were characterized by the microdilution method using a bacterial inoculum of 5 ϫ 10 5 CFU/ml of E. coli XL-1/ pBC-SK-Q119X, according to Clinical and Laboratory Standards Institute (CLSI) performance standards (16) . The antimicrobial susceptibility to penicillins, cephalosporins, and carbapenems was tested for all recombinant strains, including wild-type E. coli XL-1/pBC-SK-NDM-1 and E. coli XL-1/pBC-SK (Table 1) . Like NDM-1, all recombinant mutants exhibited resistance to penicillins, cefazolin, cefotaxime, ceftazidime, and cefepime. Only E. coli XL-1/pBC-SK-Q119E showed a MIC value of 8 g/ml for cefepime. For cefoxitin, all recombinant strains showed MIC values higher than that of E. coli XL-1/pBC-SK-NDM-1. For all strains tested, the imipenem and meropenem MIC values ranged from 1 g/ml to 16 g/ml (Table 1) . The mutants were categorized on the basis of MIC values and, in this study, only the following 6 NDM-1 variants were investigated on the basis of their phenotypic profiles: Q119C, Q119F, Q119E, Q119Y, Q119V, and Q119K. For overexpression of the 6 NDM-1 variants, the bla Q119X mutant genes, without signal peptide, were subcloned into the pET-24a(ϩ) vector and transformed into E. coli BL21(DE3). Purification of the different NDM-1 mutants was performed as described previously (15) . From 400 ml of an overnight culture in tryptic soya broth (TSB), we obtained about 5 mg of each NDM-1 mutant. Kinetic experiments were performed by following the hydrolysis of each substrate at 25°C in 25 mM sodium phosphate buffer (pH 7). The data were collected with a Perkin-Elmer Lambda 25 spectrophotometer (Perkin-Elmer Italia, Monza, Italy). Steady-state kinetic analyses were performed under initial-rate conditions using the Hanes plot linearization method (16) . For K m values of Յ10 M, the K m values were determined as K i values, using nitrocefin as the reporter substrate (17) . Each kinetic value is the mean of five different measurements; errors were Ͻ5%. In Table 2 , we show the K m , k cat , and k cat /K m values for Q119C, Q119F, Q119E, Q119Y, Q119V, and Q119K variants, compared to NDM-1 (data for NDM-1 were taken from reference 15), with some carbapenems, penicillins, and cephalosporins.
Imipenem and meropenem were good substrates for all Q119X variants analyzed, with k cat values higher than that calculated for NDM-1 (except for Q119E with imipenem). The Q119F variant showed a k cat value for meropenem of 1,500 s Ϫ1 , about value about 10-fold higher than the NDM-1 value. Cefepime, a fourth-generation cephalosporin, was more stable than cefazolin, cefoxitin, cefotaxime, and ceftazidime with all NDM-1 variants. For all Q119X variants (with rare exceptions), increases in the catalytic efficiency (k cat /K m ), compared with NDM-1, were detected with all ␤-lactams examined (Table 3 ). In particular, the Q119E, Q119Y, Q119V, and Q119K variants showed significant improvements in k cat /K m for penicillins, due to lower K m values. The catalytic efficiencies of the Q119K variant for benzylpenicillin and carbenicillin were about 65-and 70-fold higher, respectively, than those of NDM-1. The Q119K and Q119Y enzymes had k cat /K m values for ceftazidime about 25-and 89-fold higher, respectively, than that of NDM-1. The Q119E variant showed high catalytic efficiencies with penicillins but lower efficiencies with carbapenems and ceftazidime. The replacement of glutamine (Q) with cysteine (C), phenylalanine (F), glutamic acid (E), tyrosine (Y), valine (V), or lysine (K) considerably increased the activity of NDM-1 for some ␤-lactams, such as benzylpenicillin, carbenicillin, meropenem (except Q119E), ceftazidime (particularly true for Q119Y and Q119K), and cefepime (particularly true for Q119Y and Q119V). However, no clear correlation between the MIC values and the kinetic data could be observed, mainly because the MIC values for the majority of substrates did not differ substantially between wild-type NDM-1 and the mutants. For cefazolin, cefoxitin, and meropenem, the Q119V variant was always the most efficient enzyme (up to 10-fold greater than NDM-1), followed by Q119F and Q119E (about 2-to 5-fold greater than NDM-1). For benzylpenicillin, carbenicillin, cefotaxime, ceftazidime, and meropenem, Q119K was the most efficient enzyme, with catalytic efficiencies about 66-, 69-, 20-, 25-, and 10-fold higher, respectively, than those of NDM-1.
Residue 119 is positioned in the L5 loop, which includes important catalytic residues such as H116, H118, and D120. Q119 is adjacent to D120 and we presume that it could play an important role in the activities of NDM-1. Structural studies of NDM-1 (18) suggested that Q119 maintains the correct orientation of H118 and D120 in the Zn-1 coordination and therefore plays a major role in the catalytic properties of NDM-1. The study by Chiou et al. demonstrated that Q119D and Q119A mutants showed reduced carbapenem, ampicillin, and cefepime MIC values and Q119D showed reductions in k cat values for the same ␤-lactams (18); this seems to be a discrepancy with respect to the results obtained with our mutants, for which substitutions at position 119 led to enzymes with major activity, compared to the wild-type NDM-1 enzyme. The results obtained in the present study suggest that the involvement of residue 119 in NDM-1 activity is related to the amino acid structure. Our results highlight this position as a good candidate for the evolution of the NDM MBLs.
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